NCT02915445View on ClinicalTrials.gov

EpCAM CAR-T for Treatment of Advanced Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions
Malignant Neoplasm of Nasopharynx TNM Staging Distant Metastasis (M)Breast Cancer RecurrentGastric Cancer With Metastasis
Interventions
BIOLOGICAL

EpCAM CAR-T cells

Patients included will be infused the autologous T cells armed with CAR recognizing EpCAM. After infusion, cytokines and other medical test will be performed.

Trial Locations (1)

610041

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Sichuan University

OTHER